#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised


article has not abstract


Vyšlo v časopise: How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised. PLoS Med 8(8): e32767. doi:10.1371/journal.pmed.1001072
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001072

Souhrn

article has not abstract


Zdroje

1. International Committee of Medical Journal Editors 1985 Guidelines on authorship. BMJ 291 722

2. International Committee of Medical Journal Editors 2011 Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publications. Available: http://www.icmje.org/. Accessed 6 July 2011

3. DavidoffFDeAngelisCDDrazenJMNichollsMGHoeyJ 2001 Sponsorship, authorship and accountability. CMAJ 165 786 788

4. De AngelisCDDrazenJMFrizelleFAHaugCHoeyJ 2005 Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Lancet 365 1827 1829

5. DrazenJMde LeeuwPWLaineCMulrowCDeAngelisCD 2010 Toward more uniform conflict disclosures--the updated ICMJE conflict of interest reporting form. N Engl J Med 363 188 189

6. MathesonAD 2008 Corporate science and the husbandry of scientific and medical knowledge by the pharmaceutical industry. BioSocieties 3 355 382

7. Fugh-BermanAJ 2010 The haunting of medical journals: how ghostwriting sold “HRT”. PLoS Med 7 9 e1000335 doi:10.1371/journal.pmed.1000335

8. The PLoS Medicine Editors 2009 Ghostwriting: the dirty little secret of medical publishing that just got bigger. PLoS Med 6 9 e1000156 doi:10.1371/journal.pmed.1000156

9. SismondoSDoucetM 2010 Publication ethics and the ghost management of medical publication. Bioethics 24 273 283

10. EgilmanDDruarN 2011 Corporate versus public interests: community responsibility to defend scientific integrity. International Journal of Occupational and Environmental Health 17 181 185

11. Moynihan R 2008 Key opinion leaders: independent experts or drug representatives in disguise? BMJ 336 1402 1403

12. RennieDYankVEmanuelL 1997 When authorship fails. A proposal to make contributors accountable. JAMA 278 7 579 585

13. SmithR 1997 Authorship is dying: long live contributorship. BMJ 315 696

14. World Association of Medical Editors 2005 Ghost writing initiated by commercial companies. Available: http://www.wame.org/resources/policies#ghost. Accessed 6 July 2011

15. Council of Science 2009 White paper on promoting integrity in scientific journal publications. Available: http://www.councilscienceeditors.org/i4a/pages/index.cfm?pageid=3355. Accessed 6 July 2011

16. International Society for Medical Publication Professionals Issues and Actions Committee 2010 Professional medical writing. Available: http://www.ismpp.org/initiatives/Files/ISMPP_Ghost_Writing_vs_Professional_Medical_Writing.pdf. Accessed 6 July 2011

17. European Medical Writers Association Ghostwriting positioning statement. Available: http://www.emwa.org/Home/Ghostwriting-Positioning-Statement.html. Accessed 6 July 2011

18. American Medical Writers Association 2009 AMWA ethics FAQs. Available: http://www.amwa.org/default.asp?Mode=DirectoryDisplay&DirectoryUseAbsoluteOnSearch=True&id=466. Accessed 6 July 2011

19. IlakovacVFisterKMarusicMMarusicA 2007 Reliability of disclosure forms of authors' contributions. CMAJ 176 41 46

20. Pharmaceu Reasearch and Manufacturers of America 2009 Principles on conduct of clinical trials. Communication of clinical trial results. Washington (D.C.)Pharmaceutical Research and Manufacturers of America Available: http://www.phrma.org/sites/default/files/105/042009_clinical_trial_principles_final.pdf. Accessed 6 July 2011

21. GrafCBattistiWPBridgesDBruce-WinklerVConatyJM 2009 Research methods & Reporting. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 339 b4330 doi:10.1136/bmj.b4330

22. JacobsAWagerE 2005 European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin 21 2 317 322

23. GøtzschePCKassirerJPWoolleyKLWagerEJacobsA 2009 What should be done to tackle ghostwriting in the medical literature? PLoS Med 6 2 e1000023 doi:10.1371/journal.pmed.1000023

24. British Medical Journal 2011 Article submission. Provenance of articles. Available : http://resources.bmj.com/bmj/authors/authors/article-submission/submitting-an-article-to-the-bmj#provenance. Accessed 6 July 2011

25. World Association of Medical Editors 2007 Authorship. Available: http://www.wame.org/resources/policies#authorship. Accessed 6 July 2011

26. Neurology 2010 Information for authors. Available: http://www.neurology.org/misc/auth2.xhtml. Accessed 6 July 2011

27. Proceedings of the National Academy of Sciences 2011 Information for authors. Journal policies. Authorship. Available: http://www.pnas.org/site/misc/iforc.shtml#ii. Accessed 6 July 2011

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2011 Číslo 8
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#